🇺🇸 FDA
Patent

US 11471509

Compositions and methods relating to myomaker-induced muscle cell fusion

granted A61KA61K38/1719A61K45/06

Quick answer

US patent 11471509 (Compositions and methods relating to myomaker-induced muscle cell fusion) held by The Board of Regents of the University of Texas System expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/1719, A61K45/06, A61K9/0019